PAPILLARY RENAL CARCINOMA

Clinical trials for PAPILLARY RENAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PAPILLARY RENAL CARCINOMA trials appear

Sign up with your email to follow new studies for PAPILLARY RENAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental drug targets rare genitourinary cancers in new trial

Disease control Not yet recruiting

This phase 2 trial tests an experimental drug called sacituzumab tirumotecan in people with two rare types of cancer: papillary renal carcinoma and less common forms of bladder cancer. The drug is given by IV every two weeks for up to three years. The main goal is to see how many…

Matched conditions: PAPILLARY RENAL CARCINOMA

Phase: PHASE2 • Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC

PAPILLARY RENAL CARCINOMA

Get alerted when new PAPILLARY RENAL CARCINOMA trials appear

Experimental drug targets rare genitourinary cancers in new trial